Patient with histologically confirmed melanoma (stage I, II, III or IV based on AJCC classification)
Able to sign the informed collection consent for the retrospective part or to express their non-opposition to the research for the prospective part of the study
You may not be if
Subject under guardianship or subject deprived of freedom
Persons benefiting from special protection (as defined in Articles L1121-5 and L1121-8 of the Public Health Code): minors, pregnant or breastfeeding women, adults protected by law (under guardianship, curatorship or deprived of liberty) and persons hospitalized without their consent (as defined in Articles L3212-1 and L3212-3 of the Public Health Code).
ocular melanoma
Clareo Health | Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients
